Privia Health Group(PRVA)
$24.04-0.33 (-1.35%)
PRVA
Privia Health Group financials statements
$24.04
At close:-0.33 (-1.35%)
Want to see PRVA full AI Analyst Report?
Privia Health Group (PRVA) Ratios
223 Followers
Privia Health Group Ratios
PRVA's free cash flow for Q3 2026 was $28.94M. For the 2026 fiscal year, PRVA's free cash flow was increased by $0.00 and operating cash flow was $28.94M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.60 | 1.86 | 1.81 | 2.09 | 2.35 |
| Quick Ratio | 1.60 | 1.86 | 1.81 | 2.09 | 2.35 |
| Cash Ratio | 0.84 | 1.09 | 1.01 | 1.32 | 1.68 |
| Solvency Ratio | 0.06 | 0.05 | 0.08 | -0.01 | -0.79 |
| Operating Cash Flow Ratio | 0.29 | 0.24 | 0.21 | 0.18 | 0.29 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 62.92 |
| Net Current Asset Value | $ 332.57M | $ 382.49M | $ 308.29M | $ 278.20M | $ 210.48M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.00 | 0.01 | 0.01 | 0.07 |
| Debt-to-Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.11 |
| Debt-to-Capital Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.10 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 |
| Financial Leverage Ratio | 1.86 | 1.79 | 1.78 | 1.59 | 1.61 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -96.20 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -203.21 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Interest Debt Per Share | 0.08 | 0.05 | 0.07 | 0.10 | 0.44 |
| Net Debt to EBITDA | -8.73 | -13.82 | -14.02 | 23.12 | 1.27 |
| Profitability Margins | |||||
| Gross Profit Margin | 9.87% | 10.19% | 9.74% | 9.93% | 6.59% |
| EBIT Margin | 2.07% | 1.61% | 1.25% | -1.41% | -22.50% |
| EBITDA Margin | 2.54% | 2.02% | 1.64% | -1.07% | -22.25% |
| Operating Profit Margin | 1.61% | 0.98% | 1.25% | -1.41% | -22.50% |
| Pretax Profit Margin | 2.07% | 1.61% | 1.75% | -1.37% | -22.61% |
| Net Profit Margin | 1.08% | 0.83% | 1.39% | -0.63% | -19.48% |
| Continuous Operations Profit Margin | 1.40% | 0.98% | 1.27% | -0.89% | -19.73% |
| Net Income Per EBT | 52.16% | 51.61% | 79.53% | 46.21% | 86.14% |
| EBT Per EBIT | 128.34% | 164.11% | 140.54% | 97.17% | 100.49% |
| Return on Assets (ROA) | 1.67% | 1.27% | 2.31% | -1.08% | -27.42% |
| Return on Equity (ROE) | 3.11% | 2.26% | 4.11% | -1.72% | -44.10% |
| Return on Capital Employed (ROCE) | 4.27% | 2.47% | 3.37% | -3.62% | -43.85% |
| Return on Invested Capital (ROIC) | 2.88% | 1.51% | 2.43% | -2.34% | -37.97% |
| Return on Tangible Assets | 2.43% | 1.63% | 3.06% | -1.41% | -37.74% |
| Earnings Yield | 0.79% | 0.62% | 0.86% | -0.34% | -6.75% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.30 | 5.49 | 5.70 | 7.16 | 8.23 |
| Payables Turnover | 239.99 | 159.87 | 189.83 | 181.53 | 303.58 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 228.31 | 286.06 | 185.49 | 118.23 | 68.35 |
| Asset Turnover | 1.55 | 1.53 | 1.66 | 1.71 | 1.41 |
| Working Capital Turnover Ratio | 5.83 | 4.96 | 5.51 | 4.99 | 6.46 |
| Cash Conversion Cycle | 67.41 | 64.18 | 62.10 | 49.00 | 43.15 |
| Days of Sales Outstanding | 68.93 | 66.46 | 64.02 | 51.01 | 44.35 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 1.52 | 2.28 | 1.92 | 2.01 | 1.20 |
| Operating Cycle | 68.93 | 66.46 | 64.02 | 51.01 | 44.35 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.34 | 0.92 | 0.69 | 0.43 | 0.51 |
| Free Cash Flow Per Share | 1.33 | 0.87 | 0.69 | 0.43 | 0.51 |
| Dividend Paid and CapEx Coverage Ratio | 136.17 | 21.76 | 714.91 | 453.81 | 100.65 |
| Capital Expenditure Coverage Ratio | 136.17 | 21.76 | 714.91 | 453.81 | 100.65 |
| Operating Cash Flow Coverage Ratio | 17.14 | 19.55 | 9.75 | 4.10 | 1.18 |
| Operating Cash Flow to Sales Ratio | 0.08 | 0.06 | 0.05 | 0.03 | 0.06 |
| Free Cash Flow Yield | 5.60% | 4.47% | 3.00% | 1.87% | 1.95% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 124.79 | 162.92 | 116.48 | -292.82 | -14.82 |
| Price-to-Sales (P/S) Ratio | 1.36 | 1.34 | 1.62 | 1.85 | 2.89 |
| Price-to-Book (P/B) Ratio | 3.93 | 3.68 | 4.79 | 5.04 | 6.54 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 17.86 | 22.39 | 33.32 | 53.38 | 51.18 |
| Price-to-Operating Cash Flow Ratio | 17.73 | 21.36 | 33.28 | 53.26 | 50.67 |
| Price-to-Earnings Growth (PEG) Ratio | 2.14 | -4.07 | -0.41 | 3.12 | 0.02 |
| Enterprise Value Multiple | 45.07 | 52.61 | 84.88 | -149.64 | -11.70 |
| Enterprise Value | 2.43B | 1.85B | 2.31B | 2.18B | 2.52B |
| EV to EBITDA | 45.07 | 52.61 | 84.88 | -149.64 | -11.70 |
| EV to Sales | 1.14 | 1.06 | 1.39 | 1.60 | 2.60 |
| EV to Free Cash Flow | 14.96 | 17.73 | 28.60 | 46.24 | 46.15 |
| EV to Operating Cash Flow | 14.85 | 16.92 | 28.56 | 46.14 | 45.69 |
| Tangible Book Value Per Share | 2.99 | 3.62 | 3.09 | 3.02 | 2.43 |
| Shareholders’ Equity Per Share | 6.03 | 5.32 | 4.81 | 4.51 | 3.96 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.32 | 0.39 | 0.28 | 0.35 | 0.13 |
| Revenue Per Share | 17.38 | 14.54 | 14.20 | 12.26 | 8.96 |
| Net Income Per Share | 0.19 | 0.12 | 0.20 | -0.08 | -1.75 |
| Tax Burden | 0.52 | 0.52 | 0.80 | 0.46 | 0.86 |
| Interest Burden | 1.00 | 1.00 | 1.41 | 0.97 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.08 | 0.09 | 0.07 | 0.10 | 0.26 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.05 | 0.26 |
| Income Quality | 7.13 | 7.60 | 3.50 | -3.91 | -0.29 |
Currency in USD
